Clinical and public health implications of glycemic relapse in type 2 diabetes: Commentary

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 1, 2007, Pages 10-11

  O'Connor, Patrick J ^a   Sperl Hillen, JoAnn ^a  

^a HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HAZARD RATIO; HOME MONITORING; HUMAN; HYPERGLYCEMIA; INCIDENCE; INSULIN RELEASE; INTENSIVE CARE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OUTPATIENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; PUBLIC HEALTH; RELAPSE; SELF CARE; WEIGHT GAIN;

EID: 33845725308     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0354     Document Type: Note

References (5)

1. Saaddine JB et al. (2006) Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 144: 465-474
2. No authors listed (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853
3. Sperl-Hillen JM and O'Connor PJ (2005) Factors driving diabetes care improvement in a large medical group: ten years of progress. Am J Manag Care 11 (Suppl): S177-S185
4. 1c goals [abstract]. Diabetes 54 (Suppl 1): A303
5. O'Connor PJ (2006) Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med 166: 1802-1804